Price $151.67 |
Market Cap
5.58B
|
Sector Health Care |
Div. Growth
-16.50%
|
|
P/E
23.5
|
P/B
3.9
|
P/S
1.6
|
Dividend %
0.20%
|
|
P/CF
36.7
|
P/FCF
29.5
|
Op. Cash Flow
341.6K
|
FCF
3.4
|
|
Op. Margin
8.60%
|
Net Margin
7.00%
|
ROE
18.30%
|
ROI
16.60%
|
|
ROA
6.50%
|
EPS Growth
-6.90%
|
Current Ratio
1.3
|
Debt/Equity
12.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $3.16 | - | - | 2.3M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $108.39 | - | - | 8.13B | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.45 | - | - | 4.1M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
